APA (7th ed.) Citation

DeCensi, A., Johansson, H., Helland, T., Puntoni, M., Macis, D., Aristarco, V., . . . Mellgren, G. (2021). Association of CYP2D6 genotype and tamoxifen metabolites with breast cancer recurrence in a low-dose trial. NPJ breast cancer, 7(1), 34-5. https://doi.org/10.1038/s41523-021-00236-6

Chicago Style (17th ed.) Citation

DeCensi, Andrea, et al. "Association of CYP2D6 Genotype and Tamoxifen Metabolites with Breast Cancer Recurrence in a Low-dose Trial." NPJ Breast Cancer 7, no. 1 (2021): 34-5. https://doi.org/10.1038/s41523-021-00236-6.

MLA (9th ed.) Citation

DeCensi, Andrea, et al. "Association of CYP2D6 Genotype and Tamoxifen Metabolites with Breast Cancer Recurrence in a Low-dose Trial." NPJ Breast Cancer, vol. 7, no. 1, 2021, pp. 34-5, https://doi.org/10.1038/s41523-021-00236-6.